DASH vs RPTX · P/E 76, rev $8.49B vs $61.8M cap
DoorDash, Inc. Class A Common Stock (DASH) versus Repare Therapeutics Inc (RPTX) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Repare Therapeutics Inc (RPTX) is a biotechnology company listed on US.
Latest reported DASH revenue for 2026-06-30 was $8.49B. Net income was $384.0M. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
RPTX does not have a complete income-statement cache yet.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. RPTX currently screens at market cap $61.8M.
Not investment advice. Open the DASH and RPTX stock pages for the full models.
Not investment advice.